Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2014
07/02/2014CN102274285B 一种用于2型糖尿病及并发症的药物组合物 Pharmaceutical composition for type 2 diabetes and complications
07/02/2014CN102274164B 帕潘立酮及帕潘立酮衍生物的注射用缓释凝胶剂 Injectable sustained-release gel Paliperidone and Paliperidone Derivatives
07/02/2014CN102242154B 一种生产蝉拟青霉菌丝体的液体发酵方法及其培养产物的应用 A method of fermentation liquid Paecilomyces mycelium production cicadas and culture product applications
07/02/2014CN102229606B 含异噁唑杂环的2-甲基苯并呋喃类衍生物及制备与应用 2-containing heterocyclic isoxazole derivatives and preparation and application methylbenzofuran class
07/02/2014CN102229603B 含三唑杂环的2-甲基苯并呋喃类化合物及其制备与应用 Triazole-containing heterocyclic compounds and their preparation and application 2- methyl benzofuran
07/02/2014CN102212008B 丹参素川芎嗪衍生物及其制备方法和应用 Danshensu TMP derivatives and preparation method and application
07/02/2014CN102209713B 作为5-羟色胺-6配体的1-(芳磺酰基)-4-(哌嗪-1-基)-1h-苯并咪唑 As the serotonin ligand -6 1- (arylsulfonyl) -4- (piperazin-1-yl) -1h--benzimidazole
07/02/2014CN102186473B 用于治疗周围神经病的化合物 Compounds for the treatment of peripheral neuropathy
07/02/2014CN102137862B 作为nadph氧化酶抑制剂的吡唑并吡啶衍生物 As nadph oxidase inhibitors pyrazolo pyridine derivatives
07/02/2014CN102065858B 使用唑尼沙胺和阿坎酸治疗阿尔茨海默病和相关病症的组合组合物 Use of zonisamide and acamprosate treatment of Alzheimer's disease and related disorders, a combination thereof
07/02/2014CN102001959B 一种药物晶体及其制备方法和用途 A pharmaceutical crystal and its preparation and use
07/02/2014CN101890030B 抗菌、抗病毒、抗氧化及抗色素沉积的组合物 Antibacterial, antiviral, antioxidant and anti-pigmentation composition
07/02/2014CN101784558B 神经甾体化合物 Neural Steroids
07/02/2014CN101472911B 三取代的1,2,4-三唑 Tri-substituted 1,2,4-triazole
07/01/2014US8765801 Polymorphs of azabicyclohexane
07/01/2014US8765789 2-pyridinecarboxamide derivatives
07/01/2014US8765783 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation
07/01/2014US8765680 Method for administering omega-conopeptide
07/01/2014US8765677 Omega conotoxin peptides
07/01/2014US8765174 Chewable soft capsule
07/01/2014US8765150 Riluzole aqueous suspensions
07/01/2014US8763604 Methods for treating allergy
06/2014
06/26/2014WO2014100833A1 Benzamide compounds and related methods of use
06/26/2014WO2014100728A1 Deuterium substituted fumarate derivatives
06/26/2014WO2014100624A1 Stable liquid remifentanil formulations
06/26/2014WO2014100601A2 Treatment of alzheimer's disease using tolfenamic acid
06/26/2014WO2014100541A1 Substituted pyridine-2-carboxamide compounds as apoptosis signal-regulating kinase inhibitors
06/26/2014WO2014100540A1 Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
06/26/2014WO2014100533A1 NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 δ/ε INHIBITORS
06/26/2014WO2014100501A1 Small molecule agonists of neurotensin receptor 1
06/26/2014WO2014100438A1 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
06/26/2014WO2014100359A1 Novel ergoline derivatives and uses thereof
06/26/2014WO2014100353A1 8'-hydroxy-dihydroergotamine compounds and compositions
06/26/2014WO2014100228A1 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
06/26/2014WO2014100227A1 Transthyretin stabilizers and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
06/26/2014WO2014100022A1 Dietary oligosaccharides to enhance learning and memory
06/26/2014WO2014099696A1 2-pyridyloxy-4-ester orexin receptor antagonists
06/26/2014WO2014098831A1 4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
06/26/2014WO2014098512A1 Pharmaceutical composition comprising fucosterol, as active ingredient, for preventing or treating neurodegenerative diseases
06/26/2014WO2014098306A1 Pharmaceutical composition for preventing or treating dementia
06/26/2014WO2014098295A1 Composition for preventing or treating oxidative brain damage and brain dysfunction, and production method for same
06/26/2014WO2014098249A1 Composition having tissue repairing activity and utilization thereof
06/26/2014WO2014098098A1 Heterocyclic amide derivative, and medicine containing same
06/26/2014WO2014097978A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISEASE INVOLVING ABNORMAL ACCUMULATION OF AMYLOID β PROTEIN
06/26/2014WO2014097474A1 Novel compound for imaging tau protein accumulated in the brain
06/26/2014WO2014097259A1 Composition comprising raphanus, theobroma and passiflora for treating opioid and alcohol abuse
06/26/2014WO2014097038A1 CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
06/26/2014WO2014096958A1 Inosine monophosphate and salts thereof for use in the treatment of complement-related disorders
06/26/2014WO2014096941A1 Cyclic sulfonamides as sodium channel blockers
06/26/2014WO2014096402A1 Enzyme having a nmda receptor antagonist activity and/or an anticholinergic activity
06/26/2014WO2014096384A1 Use of antisecretory factor (af) in glioblastoma treatment
06/26/2014WO2014096377A1 Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
06/26/2014WO2014096373A1 Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof
06/26/2014WO2014096321A1 Antibodies specific to tau phosphorylated at serine 422 and uses for the treatment and diagnosis of tauopathies
06/26/2014WO2014096212A1 NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
06/26/2014WO2014096093A1 3,5-diarylazaindoles as dyrk1a protein inhibitors for the treatment of cognitive deficiences associated with down's syndrome and with alzheimer's disease
06/26/2014WO2014095775A1 Bet-protein-inhibiting dihydroquinoxalinones
06/26/2014WO2014095774A1 Bet-protein-inhibiting dihydropyridopyrazinones
06/26/2014WO2014095088A1 Egfr targeted therapy of neurological disorders and pain
06/26/2014WO2014094664A1 Crystal form of compound used as mineralocorticoid receptor antagonist and preparation method therefor
06/26/2014WO2014094632A1 Pharmaceutical composition for treating headache, and preparation method thereof
06/26/2014WO2014094623A1 Use of tatarian aster extract in preparing medicament for treating pain
06/26/2014WO2014094041A1 Treatment of diseases involving mucin
06/26/2014WO2014068327A3 Agents for the prevention and/or treatment of central nervous system damage
06/26/2014WO2014055977A3 Modulation of branched amino acid concentrations
06/26/2014WO2014055644A3 Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated rna decay
06/26/2014US20140180223 Transparent transdermal nicotine delivery devices
06/26/2014US20140179760 In vivo production of small interfering rnas that mediate gene silencing
06/26/2014US20140178509 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
06/26/2014US20140178392 Nogo Receptor-Mediated Blockade of Axonal Growth
06/26/2014US20140178352 Peptide inhibitors of protein kinase c
06/26/2014US20140178295 Method for Treating Psoriasis By Administering An Anti-IL-12 Antibody
06/25/2014EP2746284A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof
06/25/2014EP2746269A1 Alicyclic[c]benzopyrone derivatives and uses thereof
06/25/2014EP2745876A1 Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
06/25/2014EP2745847A1 Progestins for preventing or reducing neurodeneration or ischemic damage
06/25/2014EP2745840A2 Composition including stem cell-derived microvesicles for promoting neurogenesis
06/25/2014EP2745708A1 Antidepressant effect of ß-hydroxy-ß-methylbutyrate
06/25/2014EP2744892A1 Therapeutics using adipose cells and cell secretions
06/25/2014EP2744798A1 Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
06/25/2014EP2744797A1 Dyrk1 inhibitors and uses thereof
06/25/2014EP2744781A1 Fentanyl derivatives as ph-dependent opioid receptor agonists
06/25/2014EP2744572A1 Abuse-resistant mucoadhesive devices for delivery of buprenorphine
06/25/2014EP2744497A2 Therapeutic combinations of netupitant and palonosetron
06/25/2014EP2744488A1 Methods for ameliorating symptoms or conditions caused by stress
06/25/2014CN1884262B 4-氨基哌啶类化合物及其医药用途 4-amino-piperidine compounds and pharmaceutical use
06/25/2014CN1867322B 结晶形式的γ-氨基丁酸类似物 Crystalline form of γ- aminobutyric acid analogue
06/25/2014CN103889971A (1,l-二氧代-4-硫代吗啉基)-[6-[[3(4-氟苯基)-5-甲基-4-异噁唑基]甲氧基]-3-吡啶]-甲酮的固体形式 (1, l- dioxo-4-thiomorpholinyl) - [6 - [[3 (4-fluorophenyl) -5-methyl-4-isoxazolyl] methoxy] -3 - pyridine] - solid -methanone
06/25/2014CN103889968A 氨基苯并二氢吡喃、氨基苯并二氢噻喃及氨基-1,2,3,4-四氢喹啉衍生物,包含这些化合物的药用组合物,及其在治疗中的用途 Aminochroman, amino thiochromanone and amino-1,2,3,4-tetrahydro-quinoline derivatives, pharmaceutical compositions containing these compounds, and their use in therapy
06/25/2014CN103889951A 唑类衍生物 Azole derivative
06/25/2014CN103889508A 用于传递丁丙诺啡的防滥用性粘膜粘附剂装置 Anti abusive mucoadhesive device for delivery of buprenorphine
06/25/2014CN103889427A 1h-喹唑啉-2,4-二酮用于预防或治疗光敏性癫痫的应用 1h- quinazoline-2,4-dione for the prophylaxis or treatment of photosensitive epilepsy Application
06/25/2014CN103889423A 奈妥匹坦和帕洛诺司琼的治疗性组合 Chennai duly horses Tanzania and palonosetron therapeutic compositions
06/25/2014CN103889415A 用于肌萎缩性侧索硬化症的治疗或病情进展抑制的药剂 For the treatment or progression of amyotrophic lateral sclerosis drug suppression
06/25/2014CN103889414A 药物组合物 The pharmaceutical composition of
06/25/2014CN103889407A 用于甲状腺素运载蛋白相关的淀粉样变性的新疗法 For new therapies for amyloidosis associated with transthyretin
06/25/2014CN103881973A 一种用于诱导分化间充质干细胞的培养基及其方法 An inter-induced differentiation of mesenchymal stem cell culture media and methods for
06/25/2014CN103881879A 一种安神补血草莓果酒 One kind of nerves and blood strawberry wine
06/25/2014CN103880964A 一种重组融合蛋白vip-tat及其应用 A recombinant fusion protein and its application vip-tat
06/25/2014CN103880909A 甾族化合物 Steroid
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 1833